U.s. medicines spending grew in 2023 as greater access offset covid-19-related decline, says iqvia institute

Research triangle park, n.c.--(business wire)--overall spending in the u.s. market for medicines grew by 2.5% and reached $435bn in 2023. excluding the contribution from covid-19 vaccines and therapeutics, spending grew at 9.9%, according to a new report from the iqviatm institute for human data science, the use of medicines in the u.s. 2024: usage and spending trends and outlook to 2028. the drop in covid-19 vaccines and therapeutics masks the significant growth in medicines that are bringing.
IQV Ratings Summary
IQV Quant Ranking